Once you know them, they're no longer a number on a DNA vial
A 25-year genetic mystery solved: SCA4 is caused by an extra-long repetitive DNA sequence in the ZFHX3 gene that poisons nerve cells. The discovery opens therapeutic pathways, as similar protein-recycling disruptions in SCA2 already have experimental treatments under clinical trial.
- ZFHX3 gene contains abnormally long repetitive DNA sequence in SCA4 patients
- 25-year search for genetic cause finally solved using advanced sequencing technology
- SCA4 causes progressive muscle weakness, loss of coordination, difficulty speaking, and sensory loss
- Similar protein-recycling disruption in SCA2 already has experimental treatment in clinical trials
- Genetic testing now available for at-risk family members
Researchers have identified the genetic cause of spinocerebellar ataxia 4 (SCA4), a rare progressive movement disorder caused by an abnormally long version of the ZFHX3 gene that disrupts protein recycling in nerve cells.
For a quarter century, researchers watched families struggle with a progressive movement disorder that scrambled their ability to walk, speak, and feel their own limbs—and no one could say why. The genetic blueprint was clearly broken, but the exact break remained hidden. That changed this week when scientists at the University of Utah, using newly available sequencing technology, finally pinpointed the culprit: an abnormally elongated version of a gene called ZFHX3 that essentially gums up the machinery inside nerve cells.
Spinocerebellar ataxia 4, or SCA4, is a rare inherited disease that steals coordination and muscle control. People with it develop a jerky, unsteady gait. Their speech becomes slurred and difficult. Over time, sensation drains from their hands and feet. Reflexes vanish. The National Institutes of Health lists no cure. Until now, there was no known cause either—just the certainty that something genetic was at work.
The breakthrough came from studying several Utah families carrying the disease. Researchers discovered that a section of the ZFHX3 gene contained an unusually long stretch of repetitive DNA—a kind of genetic stutter. When cells carry this expanded version, something goes wrong with their ability to recycle proteins. Healthy cells constantly break down proteins that no longer function properly, a process essential to cellular survival. The SCA4 mutation appears to jam this recycling system, allowing toxic protein clumps to accumulate inside nerve cells until they sicken and fail.
"This mutation is a toxic expanded repeat and we think that it actually jams up how a cell deals with unfolded or misfolded proteins," explained Dr. Stefan Pulst, chair of neurology at the University of Utah School of Medicine and senior researcher on the study, published Monday in Nature Genetics. The finding matters because it points toward potential solutions. A similar protein-recycling malfunction occurs in another movement disorder called SCA2, and researchers are already testing a therapy for that condition in clinical trials. The possibility now exists that such a treatment might work for SCA4 as well.
Beyond the laboratory, the discovery has immediate human consequences. Pattie Figueroa, the lead researcher and a project manager in neurology at the University of Utah, has worked on SCA4 since 2010, when the first affected family approached her. She has visited their homes, learned their names, watched the disease's progression. "Once you go to their homes and get to know them, they're no longer the number on the DNA vial," she said. "These are people you see every day. You can't walk away. This is not just science. This is somebody's life."
Family members now have the option to be tested for the genetic change. Knowing whether they carry the mutation allows them to prepare for the disease's onset, to plan their lives with clearer information about what lies ahead. For some, that answer brings relief or clarity. For others, it brings difficult knowledge. But it is knowledge—an end to the mystery that has shadowed these families for decades. And in rare disease research, understanding the cause is always the essential first step toward finding a cure.
Citações Notáveis
This mutation is a toxic expanded repeat and we think that it actually jams up how a cell deals with unfolded or misfolded proteins.— Dr. Stefan Pulst, chair of neurology at the University of Utah School of Medicine
Once you go to their homes and get to know them, they're no longer the number on the DNA vial. These are people you see every day. You can't walk away. This is not just science. This is somebody's life.— Pattie Figueroa, lead researcher and project manager in neurology at the University of Utah School of Medicine
A Conversa do Hearth Outra perspectiva sobre a história
Why did it take 25 years to find something that seems, from the outside, like it should have been discoverable much sooner?
The technology simply wasn't there. You need to be able to read very long, repetitive stretches of DNA clearly, and that capability is brand new. Before, the genetic sequencing tools would get confused by these repeated sections—they'd skip over them or misread them. It's like trying to read a sentence where the same word appears fifty times in a row. Your eye just slides past it.
So the families knew something was genetic all along?
Yes. The pattern was obvious—it ran through families, it appeared in predictable ways. But knowing it's genetic and knowing which gene, and which specific mutation, are two entirely different things. It's the difference between knowing your house has a leak and finding the exact crack in the pipe.
What changes now that they've found it?
Everything becomes targetable. Before, you're treating symptoms—you can help someone walk better or speak more clearly. Now you know the actual mechanism of harm. You can ask: how do we fix the protein-recycling machinery? How do we prevent the toxic clumps from forming? There's already a drug being tested for a similar problem in another disease. That's not a coincidence anymore—it's a roadmap.
Can people in these families get tested?
They can, yes. And that's complicated. Some will want to know. Some won't. But for those who do, it means they can prepare. They can make decisions about their lives, their families, their work. They're no longer waiting for something invisible to happen.
Does finding the cause mean a cure is close?
Not necessarily close, but it means the path is visible now. Before, you're shooting in the dark. Now you're aiming at something real.